Vistagen Therapeutics, Inc. (VTGN)
0.5057
-0.04
(-7.21%)
USD |
NASDAQ |
Feb 13, 16:00
0.5057
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap : 19.97M for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alector, Inc. | 205.20M |
| ACADIA Pharmaceuticals, Inc. | 3.728B |
| Alnylam Pharmaceuticals, Inc. | 41.45B |
| Savara, Inc. | 1.140B |
| BioMarin Pharmaceutical, Inc. | 11.50B |
Market Cap Related Metrics
| PS Ratio | 17.75 |
| PEG Ratio | -0.0130 |
| Price to Book Value | 0.3011 |
| Price | 0.5057 |
| Earnings Yield | -375.3% |
| PEGY Ratio | -0.0130 |